2023 Wisconsin Multiple Myeloma & Lymphoma Summit
This CME-accredited activity, Wisconsin Multiple Myeloma & Lymphoma Summit, features leading experts in hematologic malignancies who will provide a comprehensive overview of current and emerging strategies for the management of multiple myeloma, lymphoma, and Waldenström Macroglobulinemia.
This activity aims to improve learners' knowledge and competence to apply practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients with hematologic malignancies. The program features in-depth discussion and analysis of the latest scientific findings and practice-changing advances in newly diagnosed and relapsed multiple myeloma and lymphomas with a focus on emerging immunotherapies, including but not limited to CAR-T therapy and T-cell redirecting bispecific antibodies. Expert faculty will aim to place the role of different therapeutic agents in clinical contexts and discuss how to utilize these therapeutic options to effectively contribute to patient care.
- Cancer care professionals
- Practicing medical oncologists/hematologists
- Radiation oncologists
- Medical oncology and hematology fellows
- Oncology nurses
- Nurse practitioners
- Physician assistants
Hyatt Regency Milwaukee
Upon successful completion of this educational activity, participants will be able to:
- Review strategies for induction and treatment for both transplant-eligible and transplant-ineligible with newly diagnosed multiple myeloma
Outline the management strategies for patients with 1-3 prior lines of therapy
Review indications and safety of CAR-T, bispecific antibodies MM, and lymphoma
Review the indications for the treatment of Waldenstrom Macroglobulinemia and current therapeutic strategies
Understand the evolving treatment strategies for the initial management of DLBCL
DAY 1 - Aug 25, 2023
Networking Meet & Greet: Location TBD
DAY 2 - Aug 26, 2023
07:00 AM to 08:00 AM BREAKFAST & REGISTRATION
08:00 AM to 08:15 AM WELCOME & OPENING REMARKS
08:15 AM to 09:15 AM SESSION 1: APPROACH TO NEWLY DIAGNOSED MULTIPLE MYELOMA
08:15 AM to 08:35 AM The Evolving Paradigm of Induction Therapy in Transplant-Eligible Patients
08:35 AM to 08:55 AM Transplant Ineligible Myeloma Patients: Is Proteasome Inhibitor Necessary?
08:55 AM to 09:15 AM Case-Based Panel Discussion
09:15 AM to 10:15 AM SESSION 2: RELAPSED AND REFRACTORY MYELOMA AND EMERGING THERAPIES
09:15 AM to 09:35 AM Treatment Options in Patients with Early Relapse in MM
09:35 AM to 09:55 AM How to Choose and Sequence CAR-T vs Bispecific Antibodies in MM
09.55 AM to 10:15 AM Case-Based Panel Discussion
10:15 AM to 10:40 AM BREAKS & EXHIBITS
10:40 AM to 11:40 AM SESSION 3: MANAGEMENT OF INDOLENT LYMPHOMAS
10:40 AM to 11:00 AM Treatment Update in Waldenstrom Macroglobulinemia
11:00 AM to 11:10 AM Targeted Agents and Immunotherapy in Follicular Lymphoma
11:20 AM to 11:40 AM Case-Based Panel Discussion
11:40 AM to 12:40 PM LUNCH & EXHIBITS
12:40 PM to 01:40 PM SESSION 4: MANAGEMENT OF AGGRESSIVE LYMPHOMAS
12:40 PM to 01:00 PM Frontline Treatment of Patients with DLBCL
01:00 PM to 01:20 PM CAR-T and Bispecific Antibodies in DLBCL
01:20 PM to 01:40 PM Cased-Based Panel Discussion
1:40 PM ADJOURN
A limited number of rooms have been reserved for the attendees of this conference at the Hyatt Regency Milwaukee at a discounted rate of $172/night. Reserve your room at the following link by July 28th, 2023, to receive the discounted rate: https://www.hyatt.com/en-US/group-booking/MKERM/G-MYEL
FACULTY INFORMATION COMING SOON
Accreditation coming soon...
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Physicians (non-industry) - $350
Non-physician HCP (non-industry) - $250
Industry representatives - $1250
Fellow or resident - $200
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is cancelled six weeks before the conference.
- No refunds will be issued if registration is cancelled after that date.
No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity, and completion of pre & post tests as well as course evaluations.